CEO Anne Wojcicki, who holds roughly half of voting power, is attempting to take the company private. In September, seven ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Regarding its workforce reduction, which will total 200 employees, CEO Anne Wojcicki called the layoffs a “difficult but necessary” step to keep the company alive. “We are taking these difficult but ...

This decision, described by CEO Anne Wojcicki as “difficult but necessary,” comes as the genetic testing company undergoes a ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Sales for the Atlanta-based company improved 6.6 percent to $40.22 billion, topping the $39.31 billion that analysts ...

23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...